1. Home
  2. SEPN vs APEI Comparison

SEPN vs APEI Comparison

Compare SEPN & APEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • APEI
  • Stock Information
  • Founded
  • SEPN 2022
  • APEI 1991
  • Country
  • SEPN United States
  • APEI United States
  • Employees
  • SEPN N/A
  • APEI N/A
  • Industry
  • SEPN
  • APEI Other Consumer Services
  • Sector
  • SEPN
  • APEI Consumer Discretionary
  • Exchange
  • SEPN NYSE
  • APEI Nasdaq
  • Market Cap
  • SEPN 453.2M
  • APEI 453.1M
  • IPO Year
  • SEPN 2024
  • APEI 2007
  • Fundamental
  • Price
  • SEPN $10.41
  • APEI $29.79
  • Analyst Decision
  • SEPN Buy
  • APEI Buy
  • Analyst Count
  • SEPN 4
  • APEI 6
  • Target Price
  • SEPN $27.00
  • APEI $31.60
  • AVG Volume (30 Days)
  • SEPN 559.2K
  • APEI 312.4K
  • Earning Date
  • SEPN 08-15-2025
  • APEI 08-05-2025
  • Dividend Yield
  • SEPN N/A
  • APEI N/A
  • EPS Growth
  • SEPN N/A
  • APEI N/A
  • EPS
  • SEPN N/A
  • APEI 1.02
  • Revenue
  • SEPN $977,000.00
  • APEI $634,678,000.00
  • Revenue This Year
  • SEPN N/A
  • APEI $7.12
  • Revenue Next Year
  • SEPN $526.96
  • APEI $4.17
  • P/E Ratio
  • SEPN N/A
  • APEI $29.31
  • Revenue Growth
  • SEPN 108.76
  • APEI 4.86
  • 52 Week Low
  • SEPN $4.17
  • APEI $11.80
  • 52 Week High
  • SEPN $28.99
  • APEI $30.55
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • APEI 62.80
  • Support Level
  • SEPN N/A
  • APEI $27.09
  • Resistance Level
  • SEPN N/A
  • APEI $30.55
  • Average True Range (ATR)
  • SEPN 0.00
  • APEI 1.29
  • MACD
  • SEPN 0.00
  • APEI -0.00
  • Stochastic Oscillator
  • SEPN 0.00
  • APEI 84.00

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About APEI American Public Education Inc.

American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.

Share on Social Networks: